KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 252 filers reported holding KITE PHARMA INC in Q3 2017. The put-call ratio across all filers is 1.40 and the average weighting 1.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $6,059,000 | +26.3% | 58,443 | -4.3% | 0.09% | +13.6% |
Q1 2017 | $4,796,000 | +67.4% | 61,100 | -4.4% | 0.08% | +47.3% |
Q4 2016 | $2,865,000 | -29.7% | 63,904 | -12.5% | 0.06% | -23.6% |
Q3 2016 | $4,078,000 | +73.5% | 73,000 | +55.3% | 0.07% | +60.0% |
Q2 2016 | $2,350,000 | +8.9% | 47,000 | 0.0% | 0.04% | +7.1% |
Q1 2016 | $2,158,000 | -25.5% | 47,000 | 0.0% | 0.04% | -17.6% |
Q4 2015 | $2,896,000 | +10.7% | 47,000 | 0.0% | 0.05% | +15.9% |
Q3 2015 | $2,617,000 | -14.1% | 47,000 | -6.0% | 0.04% | +100.0% |
Q2 2015 | $3,048,000 | +45.2% | 50,000 | +42.9% | 0.02% | -26.7% |
Q1 2015 | $2,099,000 | – | 35,000 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Wildcat Capital Management, LLC | 2,410,034 | $433,348,000 | 77.71% |
COWEN INC. | 4,200,600 | $755,310,000 | 26.72% |
Tyrus Capital S.A.M. | 1,314,812 | $236,416,000 | 18.49% |
OMNI PARTNERS LLP | 661,711 | $118,982,000 | 15.19% |
FNY Partners Fund LP | 379,510 | $68,239,000 | 11.61% |
EQUITEC PROPRIETARY MARKETS, LLC | 240,100 | $43,172,000 | 10.15% |
EQUITEC PROPRIETARY MARKETS, LLC | 227,500 | $40,907,000 | 9.62% |
GARDNER LEWIS ASSET MANAGEMENT L P | 773,817 | $139,140,000 | 8.89% |
Quad Capital Management Advisors LLC | 192,537 | $34,620,000 | 7.10% |
Avoro Capital Advisors LLC | 496,983 | $89,363,000 | 6.93% |